According to Latest Research, the global market for Newborn Screening for SMA and SCID should grow from US$ 129.2 million in 2022 to US$ 288 million by 2029, with a CAGR of 11.5% for the period of 2023-2029.

Global key players of newborn screening for SMA and SCID include Perkinelmer, Thermo Fisher, ImmunoIVD, Labsystems Diagnostics, etc. The top three players hold a share over 85%. North America is the largest market, has a share about 60%, followed by Europe, with share 25%.

Newborn screening is the practice of testing every newborn for certain harmful or potentially fatal disorder that isn’t otherwise apparent at birth.

This report studies and analyses global Newborn Screening for SMA and SCID status and future trends, to help determine the Newborn Screening for SMA and SCID market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Newborn Screening for SMA and SCID, and provides market size (US$ million) and Year-over-Year growth, considering 2022 as the base year.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

To assess the competitive environment within the market including supplier revenue, market share, and company profiles.

Highlights

(1) Global Newborn Screening for SMA and SCID market size, history data 2018-2023, and forecast data 2024-2029, (US$ million)

(2) Global Newborn Screening for SMA and SCID by company, revenue, market share and industry ranking 2018-2023, (US$ million)

(3) China Newborn Screening for SMA and SCID by company, revenue, market share and industry ranking 2018-2023, (US$ million)

(4) Global Newborn Screening for SMA and SCID key consuming regions, consumption value and demand structure

(5) Newborn Screening for SMA and SCID industry chains, upstream, midstream and downstream

Market segment by players, this report covers

Perkinelmer

Thermo Fisher

ImmunoIVD

Labsystems Diagnostics

Market segment by Type, covers

Instruments

Kits

Software

Market segment by Application, can be divided into

SCID Screening

SMA Screening

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Report Includes:

Chapter 1: to describe Newborn Screening for SMA and SCID product scope, global consumption value, China consumption value, development opportunities, challenges, trends, and policies.

Chapter 2: Global Newborn Screening for SMA and SCID market share and ranking of major manufacturers, revenue, 2018-2023

Chapter 3: China Newborn Screening for SMA and SCID market share and ranking of major manufacturers, revenue, 2018-2023

Chapter 4: Newborn Screening for SMA and SCID industry chain, upstream, medium-stream, and downstream.

Chapter 5: Segment by Type, consumption value, percent & CAGR, 2018-2029

Chapter 6: Segment by Application, consumption value, percent & CAGR, 2018-2029

Chapter 7: Segment in regional level, consumption value, percent & CAGR, 2018-2029

Chapter 8: Segment in country level, consumption value, percent & CAGR, 2018-2029

Chapter 9: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, revenue, gross margin.

Chapter 10: Conclusions

1 Market Overview

1.1 Newborn Screening for SMA and SCID Definition

1.2 Global Newborn Screening for SMA and SCID Market Size and Forecast

1.3 China Newborn Screening for SMA and SCID Market Size and Forecast

1.4 China Percentage in Global Market

1.5 Newborn Screening for SMA and SCID Market Size: China VS Global Growth Rate, 2018-2029

1.6 Newborn Screening for SMA and SCID Market Dynamics

1.6.1 Newborn Screening for SMA and SCID Market Drivers

1.6.2 Newborn Screening for SMA and SCID Market Restraints

1.6.3 Newborn Screening for SMA and SCID Industry Trends

1.6.4 Newborn Screening for SMA and SCID Industry Policy

2 Global Leading Players and Market Share

2.1 By Revenue of Newborn Screening for SMA and SCID, Global Market Share by Company, 2018-2023

2.2 Global Newborn Screening for SMA and SCID Participants, Market Position (Tier 1, Tier 2, and Tier 3)

2.3 Global Newborn Screening for SMA and SCID Concentration Ratio

2.4 Global Newborn Screening for SMA and SCID Mergers & Acquisitions, Expansion Plans

2.5 Global Newborn Screening for SMA and SCID Major Companies Product Type

2.6 Head Office and Newborn Screening for SMA and SCID Production Site of Key Manufacturer

3 China Leading Players, Market Share and Ranking

3.1 By Revenue of Newborn Screening for SMA and SCID, China Market Share by Company, 2018-2023

3.2 China Newborn Screening for SMA and SCID Participants, Market Position (Tier 1, Tier 2, and Tier 3)

4 Industry Chain Analysis

4.1 Newborn Screening for SMA and SCID Industry Chain

4.2 Newborn Screening for SMA and SCID Upstream Analysis

4.2.1 Newborn Screening for SMA and SCID Core Raw Materials

4.2.2 Main Manufacturers of Newborn Screening for SMA and SCID Core Raw Materials

4.3 Midstream Analysis

4.4 Downstream Analysis

4.5 Newborn Screening for SMA and SCID Production Mode

4.6 Newborn Screening for SMA and SCID Procurement Model

4.7 Newborn Screening for SMA and SCID Industry Sales Model and Sales Channels

4.7.1 Newborn Screening for SMA and SCID Sales Model

4.7.2 Newborn Screening for SMA and SCID Typical Distributors

5 Sights by Type

5.1 Newborn Screening for SMA and SCID Classification

5.1.1 Instruments

5.1.2 Kits

5.1.3 Software

5.2 By Type, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029

5.3 By Type, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029

6 Sights by Application

6.1 Newborn Screening for SMA and SCID Segment by Application

6.1.1 SCID Screening

6.1.2 SMA Screening

6.2 By Application, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029

6.3 By Application, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029

7 Sales Sights by Region

7.1 By Region, Global Newborn Screening for SMA and SCID Consumption Value, 2018 VS 2022 VS 2029

7.2 By Region, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029

7.3 North America

7.3.1 North America Newborn Screening for SMA and SCID & Forecasts, 2018-2029

7.3.2 By Country, North America Newborn Screening for SMA and SCID Market Size Market Share

7.4 Europe

7.4.1 Europe Newborn Screening for SMA and SCID Market Size & Forecasts, 2018-2029

7.4.2 By Country, Europe Newborn Screening for SMA and SCID Market Size Market Share

7.5 Asia Pacific

7.5.1 Asia Pacific Newborn Screening for SMA and SCID Market Size & Forecasts, 2018-2029

7.5.2 By Country/Region, Asia Pacific Newborn Screening for SMA and SCID Market Size Market Share

7.6 South America

7.6.1 South America Newborn Screening for SMA and SCID Market Size & Forecasts, 2018-2029

7.6.2 By Country, South America Newborn Screening for SMA and SCID Market Size Market Share

7.7 Middle East & Africa

8 Sales Sights by Country Level

8.1 By Country, Global Newborn Screening for SMA and SCID Market Size & CAGR, 2018 VS 2022 VS 2029

8.2 By Country, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029

8.3 U.S.

8.3.1 U.S. Newborn Screening for SMA and SCID Market Size, 2018-2029

8.3.2 By Type, U.S. Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.3.3 By Application, U.S. Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.4 Europe

8.4.1 Europe Newborn Screening for SMA and SCID Market Size, 2018-2029

8.4.2 By Type, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.4.3 By Application, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.5 China

8.5.1 China Newborn Screening for SMA and SCID Market Size, 2018-2029

8.5.2 By Type, China Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.5.3 By Application, China Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.6 Japan

8.6.1 Japan Newborn Screening for SMA and SCID Market Size, 2018-2029

8.6.2 By Type, Japan Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.6.3 By Application, Japan Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.7 South Korea

8.7.1 South Korea Newborn Screening for SMA and SCID Market Size, 2018-2029

8.7.2 By Type, South Korea Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.7.3 By Application, South Korea Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.8 Southeast Asia

8.8.1 Southeast Asia Newborn Screening for SMA and SCID Market Size, 2018-2029

8.8.2 By Type, Southeast Asia Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.8.3 By Application, Southeast Asia Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.9 India

8.9.1 India Newborn Screening for SMA and SCID Market Size, 2018-2029

8.9.2 By Type, India Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.9.3 By Application, India Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.10 Middle East & Africa

8.10.1 Middle East & Africa Newborn Screening for SMA and SCID Market Size, 2018-2029

8.10.2 By Type, Middle East & Africa Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

8.10.3 By Application, Middle East & Africa Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

9 Company Profile

9.1 Perkinelmer

9.1.1 Perkinelmer Company Information, Head Office, Market Area and Industry Position

9.1.2 Perkinelmer Company Profile and Main Business

9.1.3 Perkinelmer Newborn Screening for SMA and SCID Models, Specifications and Application

9.1.4 Perkinelmer Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

9.1.5 Perkinelmer Recent Developments

9.2 Thermo Fisher

9.2.1 Thermo Fisher Company Information, Head Office, Market Area and Industry Position

9.2.2 Thermo Fisher Company Profile and Main Business

9.2.3 Thermo Fisher Newborn Screening for SMA and SCID Models, Specifications and Application

9.2.4 Thermo Fisher Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

9.2.5 Thermo Fisher Recent Developments

9.3 ImmunoIVD

9.3.1 ImmunoIVD Company Information, Head Office, Market Area and Industry Position

9.3.2 ImmunoIVD Company Profile and Main Business

9.3.3 ImmunoIVD Newborn Screening for SMA and SCID Models, Specifications and Application

9.3.4 ImmunoIVD Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

9.3.5 ImmunoIVD Recent Developments

9.4 Labsystems Diagnostics

9.4.1 Labsystems Diagnostics Company Information, Head Office, Market Area and Industry Position

9.4.2 Labsystems Diagnostics Company Profile and Main Business

9.4.3 Labsystems Diagnostics Newborn Screening for SMA and SCID Models, Specifications and Application

9.4.4 Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue and Gross Margin, 2018-2023

9.4.5 Labsystems Diagnostics Recent Developments

10 Conclusion

11 Appendix

11.1 Research Methodology

11.2 Data Source

11.2.1 Secondary Sources

11.2.2 Primary Sources

11.3 Market Estimation Model

11.4 Disclaimer

Table 1. Newborn Screening for SMA and SCID Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Newborn Screening for SMA and SCID Market Restraints

Table 3. Newborn Screening for SMA and SCID Market Trends

Table 4. Newborn Screening for SMA and SCID Industry Policy

Table 5. Global Newborn Screening for SMA and SCID Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Newborn Screening for SMA and SCID Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Newborn Screening for SMA and SCID Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Newborn Screening for SMA and SCID Mergers & Acquisitions, Expansion Plans

Table 9. Global Newborn Screening for SMA and SCID Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Newborn Screening for SMA and SCID Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 12. China Newborn Screening for SMA and SCID Revenue Market Share by Company, 2018-2023

Table 13. Global Key Players of Newborn Screening for SMA and SCID Upstream (Raw Materials)

Table 14. Global Newborn Screening for SMA and SCID Typical Customers

Table 15. Newborn Screening for SMA and SCID Typical Distributors

Table 16. By Type, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Application, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Newborn Screening for SMA and SCID Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 19. By Region, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Table 20. By Country, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 21. By Country, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Table 22. By Country, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Table 23. Perkinelmer Company Information, Head Office, Market Area and Industry Position

Table 24. Perkinelmer Company Profile and Main Business

Table 25. Perkinelmer Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 26. Perkinelmer Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 27. Perkinelmer Recent Developments

Table 28. Thermo Fisher Company Information, Head Office, Market Area and Industry Position

Table 29. Thermo Fisher Company Profile and Main Business

Table 30. Thermo Fisher Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 31. Thermo Fisher Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 32. Thermo Fisher Recent Developments

Table 33. ImmunoIVD Company Information, Head Office, Market Area and Industry Position

Table 34. ImmunoIVD Company Profile and Main Business

Table 35. ImmunoIVD Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 36. ImmunoIVD Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 37. ImmunoIVD Recent Developments

Table 38. Labsystems Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 39. Labsystems Diagnostics Company Profile and Main Business

Table 40. Labsystems Diagnostics Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 41. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 42. Labsystems Diagnostics Recent Developments

List of Figures

Figure 1. Newborn Screening for SMA and SCID Picture

Figure 2. Global Newborn Screening for SMA and SCID Consumption Value, (US$ million) & (2018-2029)

Figure 3. China Newborn Screening for SMA and SCID Consumption Value, (US$ million) & (2018-2029)

Figure 4. By Consumption Value, China Newborn Screening for SMA and SCID Market Share of Global, 2018-2029

Figure 5. Global Newborn Screening for SMA and SCID Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Newborn Screening for SMA and SCID Key Participants, Market Share, 2022

Figure 7. Newborn Screening for SMA and SCID Industry Chain

Figure 8. Newborn Screening for SMA and SCID Procurement Model

Figure 9. Newborn Screening for SMA and SCID Sales Model

Figure 10. Newborn Screening for SMA and SCID Sales Channels, Direct Sales, and Distribution

Figure 11. Instruments

Figure 12. Kits

Figure 13. Software

Figure 14. By Type, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 15. By Type, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Figure 16. SCID Screening

Figure 17. SMA Screening

Figure 18. By Application, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 19. By Application, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Figure 20. By Region, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Figure 21. North America Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 23. Europe Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 25. Asia Pacific Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 27. South America Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 29. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 31. By Type, U.S. Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 33. Europe Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 34. By Type, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 35. By Application, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 36. China Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 37. By Type, China Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 38. By Application, China Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 39. Japan Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 40. By Type, Japan Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 41. By Application, Japan Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 42. South Korea Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 43. By Type, South Korea Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 44. By Application, South Korea Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 45. Southeast Asia Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 46. By Type, Southeast Asia Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 47. By Application, Southeast Asia Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 48. India Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 49. By Type, India Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 50. By Application, India Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 51. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 52. By Type, Middle East & Africa Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 53. By Application, Middle East & Africa Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 54. Research Methodology

Figure 55. Breakdown of Primary Interviews

Figure 56. Bottom-up and Top-down Approaches

Figure 57. Top-down Approaches

Table 1. Newborn Screening for SMA and SCID Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Newborn Screening for SMA and SCID Market Restraints

Table 3. Newborn Screening for SMA and SCID Market Trends

Table 4. Newborn Screening for SMA and SCID Industry Policy

Table 5. Global Newborn Screening for SMA and SCID Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Newborn Screening for SMA and SCID Revenue Share by Company, 2018-2023, Ranked by Data of 2022

Table 7. Global Newborn Screening for SMA and SCID Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Newborn Screening for SMA and SCID Mergers & Acquisitions, Expansion Plans

Table 9. Global Newborn Screening for SMA and SCID Major Companies Product Type

Table 10. Head Office and Area Served of Key Players

Table 11. China Newborn Screening for SMA and SCID Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022

Table 12. China Newborn Screening for SMA and SCID Revenue Market Share by Company, 2018-2023

Table 13. Global Key Players of Newborn Screening for SMA and SCID Upstream (Raw Materials)

Table 14. Global Newborn Screening for SMA and SCID Typical Customers

Table 15. Newborn Screening for SMA and SCID Typical Distributors

Table 16. By Type, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 17. By Application, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 18. By Region, Global Newborn Screening for SMA and SCID Consumption Value, 2018 VS 2022 VS 2029, US$ Million

Table 19. By Region, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Table 20. By Country, Global Newborn Screening for SMA and SCID Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 21. By Country, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Table 22. By Country, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Table 23. Perkinelmer Company Information, Head Office, Market Area and Industry Position

Table 24. Perkinelmer Company Profile and Main Business

Table 25. Perkinelmer Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 26. Perkinelmer Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 27. Perkinelmer Recent Developments

Table 28. Thermo Fisher Company Information, Head Office, Market Area and Industry Position

Table 29. Thermo Fisher Company Profile and Main Business

Table 30. Thermo Fisher Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 31. Thermo Fisher Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 32. Thermo Fisher Recent Developments

Table 33. ImmunoIVD Company Information, Head Office, Market Area and Industry Position

Table 34. ImmunoIVD Company Profile and Main Business

Table 35. ImmunoIVD Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 36. ImmunoIVD Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 37. ImmunoIVD Recent Developments

Table 38. Labsystems Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 39. Labsystems Diagnostics Company Profile and Main Business

Table 40. Labsystems Diagnostics Newborn Screening for SMA and SCID Models, Specifications, and Application

Table 41. Labsystems Diagnostics Newborn Screening for SMA and SCID Revenue and Gross Margin, US$ Million, 2018-2023

Table 42. Labsystems Diagnostics Recent Developments

List of Figures

Figure 1. Newborn Screening for SMA and SCID Picture

Figure 2. Global Newborn Screening for SMA and SCID Consumption Value, (US$ million) & (2018-2029)

Figure 3. China Newborn Screening for SMA and SCID Consumption Value, (US$ million) & (2018-2029)

Figure 4. By Consumption Value, China Newborn Screening for SMA and SCID Market Share of Global, 2018-2029

Figure 5. Global Newborn Screening for SMA and SCID Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 6. China Newborn Screening for SMA and SCID Key Participants, Market Share, 2022

Figure 7. Newborn Screening for SMA and SCID Industry Chain

Figure 8. Newborn Screening for SMA and SCID Procurement Model

Figure 9. Newborn Screening for SMA and SCID Sales Model

Figure 10. Newborn Screening for SMA and SCID Sales Channels, Direct Sales, and Distribution

Figure 11. Instruments

Figure 12. Kits

Figure 13. Software

Figure 14. By Type, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 15. By Type, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Figure 16. SCID Screening

Figure 17. SMA Screening

Figure 18. By Application, Global Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 19. By Application, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Figure 20. By Region, Global Newborn Screening for SMA and SCID Consumption Value Market Share, 2018-2029

Figure 21. North America Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 22. By Country, North America Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 23. Europe Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 24. By Country, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 25. Asia Pacific Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 26. By Country/Region, Asia Pacific Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 27. South America Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 28. By Country, South America Newborn Screening for SMA and SCID Consumption Value Market Share, 2022

Figure 29. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value & Forecasts, 2018-2029, US$ Million

Figure 30. U.S. Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 31. By Type, U.S. Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 32. By Application, U.S. Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 33. Europe Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 34. By Type, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 35. By Application, Europe Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 36. China Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 37. By Type, China Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 38. By Application, China Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 39. Japan Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 40. By Type, Japan Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 41. By Application, Japan Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 42. South Korea Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 43. By Type, South Korea Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 44. By Application, South Korea Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 45. Southeast Asia Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 46. By Type, Southeast Asia Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 47. By Application, Southeast Asia Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 48. India Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 49. By Type, India Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 50. By Application, India Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 51. Middle East & Africa Newborn Screening for SMA and SCID Consumption Value, 2018-2029, US$ Million

Figure 52. By Type, Middle East & Africa Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 53. By Application, Middle East & Africa Newborn Screening for SMA and SCID Consumption Value Market Share, 2022 VS 2029

Figure 54. Research Methodology

Figure 55. Breakdown of Primary Interviews

Figure 56. Bottom-up and Top-down Approaches

Figure 57. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)